Related Experiment Video
Updated: Jun 11, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Cerebral Embolic Protection: Is There a Benefit for Left Atrial and Mitral Valve Procedures?
Besir Besir1, Samir R Kapadia2
1Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, J2-3, Cleveland, OH, 44195, USA.
Insights
Cerebral embolic protection devices (CEPD) show promise in reducing stroke risk during left atrial and mitral valve procedures. Antithrombotic management is crucial for patient safety and mitigating long-term stroke risk.
Area of Science:
- Cardiovascular Interventions
- Neurology
- Medical Device Technology
Background:
- Stroke is a significant complication of structural heart interventions.
- Cerebral embolic protection devices (CEPD) were developed to reduce stroke risk, initially for transcatheter aortic valve replacement (TAVR).
- The efficacy of CEPD in left atrial appendage closure (LAAO) and mitral valve procedures requires further investigation.
Purpose of the Study:
- To review current evidence on CEPD use in left atrial and transcatheter mitral valve procedures.
- To summarize antithrombotic management strategies for these interventions.
Main Methods:
- Literature review of studies on cerebral embolic protection devices.
- Analysis of antithrombotic strategies in structural heart interventions.
- Review of periprocedural stroke risk and detection methods like DW-MRI.
Main Results:
- The risk of periprocedural stroke in left atrial and mitral valve interventions is substantial.
- Cerebral ischemic injuries are common, with debris often found on CEPD filters.
- Antithrombotic therapy is vital, tailored to individual bleeding and ischemic risk.
Conclusions:
- The risk of stroke during left atrial and transcatheter mitral valve procedures is not negligible.
- Antithrombotic therapy is essential for mitigating periprocedural and long-term stroke risk.
- Further prospective studies are needed to confirm CEPD efficacy in these procedures.
Purpose Of Review:
This review aims to highlight the current evidence on the use of cerebral embolic protection devices (CEPD) in left atrial and transcatheter mitral valve procedures. It also aims to summarize the antithrombotic management of patients undergoing such procedures.
Recent Findings:
Ischemic stroke is one of the most devastating complications of structural heart procedures. The manifestation of periprocedural stroke can range from asymptomatic and detectable only through brain imaging to major stroke with neurological deficits. CEP devices were initially developed to mitigate the risk of stroke associated with transcatheter aortic valve replacement (TAVR). However, the efficacy of such devices during different cardiac interventions is yet to be fully demonstrated, especially in left atrial appendage closure (LAAO), and mitral valve interventions. Few studies demonstrated that the risk of periprocedural strokes after LAAO and mitral valve interventions is not negligible and is highest during the periprocedural period and then falls. The majority of patients undergoing those procedures have cerebral ischemic injuries detected on diffusion-weighted magnetic resonance imaging (DW-MRI). Moreover, a reasonable number of those patients had debris embolization on the filters of the CEPD. Pharmacological therapy with antithrombotic agents before, during, or after structural heart interventions is crucial and should be tailored to each patient's risk of bleeding and ischemia. Close monitoring that includes a full neurological assessment and frequent follow-up visits with cardiac echocardiography are important. The risk of periprocedural stroke in left atrial and transcatheter mitral valve procedures is not negligible. Pharmacological therapy with antithrombotic agents before, during, or after structural heart interventions is important to mitigate the risk of stroke, especially the long-term risk. More prospective studies are needed to assess the efficacy of CEPD in such procedures.
Related Concept Videos
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Mitral Valve Prolapse II: Assessment and Management

